Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha E Taha

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Microorganisms|October 23, 2021
A Multi-Point Surveillance for Antimicrobial Resistance Profiles among Clinical Isolates of Gram-Negative Bacteria Recovered from Major Ha'il Hospitals, Saudi ArabiaKamaleldin B Said, Ahmed Alsolami, Amany M Khalifa, et al.
AIDS (London, England)|March 1, 2024
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trialSufia Dadabhai, Victoria B Chou, Mauricio Pinilla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2017
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
Plos One|November 16, 2013
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trialOliver Laeyendecker, Michal Kulich, Deborah Donnell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2021
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
The New England Journal of Medicine|November 3, 2016
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV PreventionMary G Fowler, Min Qin, Susan A Fiscus, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine|July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The American Journal of Tropical Medicine and Hygiene|December 29, 2020
Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research CollaborationJean B Nachega, Nadia A Sam-Agudu, Samantha Budhram, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Microorganisms|October 23, 2021
A Multi-Point Surveillance for Antimicrobial Resistance Profiles among Clinical Isolates of Gram-Negative Bacteria Recovered from Major Ha'il Hospitals, Saudi ArabiaKamaleldin B Said, Ahmed Alsolami, Amany M Khalifa, et al.
AIDS (London, England)|March 1, 2024
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trialSufia Dadabhai, Victoria B Chou, Mauricio Pinilla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2017
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
Plos One|November 16, 2013
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trialOliver Laeyendecker, Michal Kulich, Deborah Donnell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2021
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
The New England Journal of Medicine|November 3, 2016
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV PreventionMary G Fowler, Min Qin, Susan A Fiscus, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine|July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The American Journal of Tropical Medicine and Hygiene|December 29, 2020
Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research CollaborationJean B Nachega, Nadia A Sam-Agudu, Samantha Budhram, et al.
Pageof 13